pharmaphorum.com/news/eu-regulators-probe-safety-of-az-vaccine-batch/
‘’European safety regulators have launched an investigation into the safety of a batch of the Oxford University/AstraZeneca COVID-19 vaccine, as countries including Denmark suspended its use as a precaution following reports of blood clots.
Initial findings showed no issue with the shots suspended by Austrian authorities after a person was diagnosed with severe blood clotting and died 10 days after vaccination.
Another was hospitalised with pulmonary embolism after being vaccinated and is now recovering after being vaccinated.
In a statement, the European Medicines Agency said two other reports of blood clotting events had been received for this batch.
However, a preliminary review by the EMA’s safety committee said there is “no indication that the vaccination has caused these conditions, which are not listed as side effects with this vaccine.”
Batch ABV5300 was delivered to 17 EU countries and comprises 1 million doses of the vaccine.
Several other European countries including Denmark, Estonia, Lithuania, Luxembourg and Latvia, also subsequently suspended this batch as a precautionary measure, while the investigation is ongoing.’’